Skip to Content for Tamiflu Menu for Tamiflu About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

Tamiflu


Tamiflu

Full Prescribing Information (179K/PDF)
Important Patient Information (69K/PDF)
Important Dosing Information (144K/PDF)

12-01-2009 Physician Supply Letter (169K/PDF)

12-01-2009 Pharmacist Supply Letter (170K/PDF)

09-04-2009 Important Notice: Tamiflu® (oseltamivir phosphate) (1.24MB/PDF)

08-08-2009 Tamiflu® Capsules and Tamiflu® for Oral Suspension (oseltamivir phosphate) Stocking Program (4.64MB/PDF)

11-03-2008 Tamiflu® for Oral Suspension (oseltamivir phosphate) Short-Dated Supply Situation for 300mg/12mg/mL (275K/PDF)

08-25-2008 Stocking Program for Tamiflu® Capsules and Tamiflu® for Oral Suspension (oseltamivir phosphate) (563K/PDF)

08-25-2008 Tamiflu® (oseltamivir phosphate) Short-dated Supply Situation: Tamiflu® for Oral Suspension 300mg/12mg/mL (242K/PDF)

08-23-2006 Tamiflu® Stocking Program (486K/PDF)

Tamiflu® (oseltamivir phosphate) is prescribed for treating adults and children age 1 year and older with influenza (flu) whose symptoms started within the last day or two. Tamiflu can also reduce the chance of getting the flu in patients 1 year and older. Tamiflu is not a substitute for the annual flu vaccinations (patients should still get the flu shot every year).

Safety Information Before taking Tamiflu, patients should tell their doctor if they are pregnant or nursing, or if they have kidney disease, heart disease, respiratory disease, or other serious health conditions. Also, patients should let their doctor know if they are taking any other medications or if they have received nasally administered influenza virus vaccine during the past two weeks.

If patients develop an allergic reaction or a severe rash, they should stop taking Tamiflu and contact their healthcare professional immediately, as it may be very serious. People with the flu, particularly children and adolescents, may be at an increased risk of self injury and confusion shortly after taking Tamiflu and should be closely monitored for signs of unusual behavior. A healthcare professional should be contacted immediately if the patient taking Tamiflu shows any signs of unusual behavior.

The most common side effects are mild to moderate nausea and vomiting.

For additional important safety information, please visit www.tamiflu.com.

For More Information Please visit the Tamiflu product website.

Learn more about the flu virus.

View Material Safety Data Sheet (MSDS) for information on handling Tamiflu in a workplace such as a pharmacy or a hospital.